Literature DB >> 10893693

Posterior-anterior and lateral dual-energy x-ray absorptiometry for the assessment of vertebral osteoporosis and bone loss among older men.

J M Zmuda1, J A Cauley, N W Glynn, J S Finkelstein.   

Abstract

Lateral spine dual-energy x-ray absorptiometry (DXA) selectively measures the trabecular-rich vertebral bodies without the contributions of the cortical-rich posterior elements of the spine and is less affected by spinal degenerative disease than posterior-anterior DXA. We tested whether lateral DXA detects vertebral osteoporosis more often and is more sensitive to age-related bone loss than posterior-anterior DXA in 193 healthy, community-dwelling men aged 51-81 years (mean +/- SD; 67 +/- 8 years). All men had supine lateral, posterior-anterior, and proximal femur DXA scans on a Hologic QDR 2000 densitometer. A subset (n = 102) had repeat scans after 4 years to determine annualized rates of change in bone mineral density (BMD). Age was inversely and significantly associated with BMD in the midlateral (r = -0.27) and lateral (r = -0.24) but not posterior-anterior (r = 0.04) projections. Midlateral (-1.43 +/- 3.48% per year; p = 0.0001), lateral (-0.27 +/- 1.68% per year; p = 0.12), and hip (-0.19 +/- 1.02% per year; p = 0.06) BMD decreased, whereas posterior-anterior BMD increased (0.73 +/- 1.11% per year; p = 0.0001) during follow-up. When compared with normal values in 43 men aged 21-42 years, mean T scores were significantly lower with lateral (-1.47 +/- 1.32) and midlateral (-1.57 +/- 1.36) than posterior-anterior (-0.12 +/- 1.30; p < 0.0001) DXA. Only 2.6% of the older men were considered osteoporotic (T score < or = -2.5) at the posterior-anterior spine, whereas 11.0% were osteoporotic at the femoral neck, 22.5% at the lateral spine, and 24.6% were osteoporotic at the midlateral spine. We conclude that supine lateral DXA identifies considerably more men as osteoporotic and is more sensitive to age-related bone loss than posterior-anterior DXA. Spinal osteoporosis may represent a substantially greater health problem among older men than previously recognized.

Entities:  

Mesh:

Year:  2000        PMID: 10893693     DOI: 10.1359/jbmr.2000.15.7.1417

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  13 in total

1.  QCT measures of bone strength at the thoracic and lumbar spine: the Framingham Study.

Authors:  Elizabeth J Samelson; Blaine A Christiansen; Serkalem Demissie; Kerry E Broe; Qiong Louie-Gao; L Adrienne Cupples; Benjamin J Roberts; Rajaram Manoharam; John D'Agostino; Thomas Lang; Douglas P Kiel; Mary L Bouxsein
Journal:  J Bone Miner Res       Date:  2012-03       Impact factor: 6.741

2.  Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial.

Authors:  Peter J Snyder; David L Kopperdahl; Alisa J Stephens-Shields; Susan S Ellenberg; Jane A Cauley; Kristine E Ensrud; Cora E Lewis; Elizabeth Barrett-Connor; Ann V Schwartz; David C Lee; Shalender Bhasin; Glenn R Cunningham; Thomas M Gill; Alvin M Matsumoto; Ronald S Swerdloff; Shehzad Basaria; Susan J Diem; Christina Wang; Xiaoling Hou; Denise Cifelli; Darlene Dougar; Bret Zeldow; Douglas C Bauer; Tony M Keaveny
Journal:  JAMA Intern Med       Date:  2017-04-01       Impact factor: 21.873

3.  Denosumab is really effective in the treatment of osteoporosis secondary to hypogonadism in prostate carcinoma patients? A prospective randomized multicenter international study.

Authors:  Carlo Doria; Paolo Tranquilli Leali; Federico Solla; Gianluca Maestretti; Massimo Balsano; Robero Mario Scarpa
Journal:  Clin Cases Miner Bone Metab       Date:  2017-02-10

4.  Lateral spine dual-energy X-ray absorptiometry and the risk of fragility fractures in long-term kidney graft recipients.

Authors:  Mayuko Hori; Kaoru Yasuda; Hiroshi Takahashi; Yutaka Matsuoka; Makoto Tsujita; Morikuni Nishihira; Kazuharu Uchida; Kunio Morozumi; Shoichi Maruyama
Journal:  Clin Exp Nephrol       Date:  2022-03-18       Impact factor: 2.801

Review 5.  Bisphosphonates to prevent osteoporosis in men receiving androgen deprivation therapy for prostate cancer.

Authors:  Matthew R Smith
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

6.  Genetic influences on bone loss in the San Antonio Family Osteoporosis study.

Authors:  J R Shaffer; C M Kammerer; J M Bruder; S A Cole; T D Dyer; L Almasy; J W MacCluer; J Blangero; R L Bauer; B D Mitchell
Journal:  Osteoporos Int       Date:  2008-04-15       Impact factor: 4.507

7.  Reliability of vertebral fracture assessment using multidetector CT lateral scout views: the Framingham Osteoporosis Study.

Authors:  E J Samelson; B A Christiansen; S Demissie; K E Broe; Y Zhou; C A Meng; W Yu; X Cheng; C J O'Donnell; U Hoffmann; H K Genant; D P Kiel; M L Bouxsein
Journal:  Osteoporos Int       Date:  2010-05-21       Impact factor: 4.507

8.  High prevalence of vertebral fractures in seizure patients with normal bone density receiving chronic anti-epileptic drugs.

Authors:  P M Dussault; D McCarthy; S A Davis; M Thakore-James; A A Lazzari
Journal:  Osteoporos Int       Date:  2021-04-06       Impact factor: 4.507

9.  Genetic markers for ancestry are correlated with body composition traits in older African Americans.

Authors:  J R Shaffer; C M Kammerer; D Reich; G McDonald; N Patterson; B Goodpaster; D C Bauer; J Li; A B Newman; J A Cauley; T B Harris; F Tylavsky; R E Ferrell; J M Zmuda
Journal:  Osteoporos Int       Date:  2007-01-18       Impact factor: 5.071

10.  Glucocorticoid-induced bone loss is associated with abnormal intravertebral areal bone mineral density distribution.

Authors:  Louise I Manning; Andrew M Briggs; Sharon Van Doornum; Ashwini Kale; Susan Kantor; John D Wark
Journal:  Int J Endocrinol       Date:  2013-05-08       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.